MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
Matea PavicM NiyaziL WilkeS CorradiniM VornhülzU MansmannA Al TawilR FritschJ Hörner-RieberJ DebusM GuckenbergerC BelkaJ MayerleG BeyerPublished in: Radiation oncology (London, England) (2022)
German Registry for Clinical Trials (DRKS): DRKS00025801. Meanwhile the study is also registered at ClinicalTrials.gov with the Identifier: NCT05114213.